Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-052233
Filing Date
2025-04-08
Accepted
2025-04-08 18:19:03
Documents
1
Period of Report
2025-01-01

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 4814
  Complete submission text file 0000950170-25-052233.txt   7614
Mailing Address NEWTONLAAN 91 PO BOX 85067 3508 UTRECHT P7 AB
Business Address NEWTONLAAN 91 PO BOX 85067 3508 UTRECHT P7 AB 31(0)30-2192549
Gilde Healthcare Holding B.V. (Reporting) CIK: 0001420106 (see all company filings)

State of Incorp.: P7 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40241 | Film No.: 25823213

Mailing Address NEWTONLANN 51 UTRECHT P7 3508AB
Business Address NEWTONLANN 51 UTRECHT P7 3508AB 949-396-6322
Cooperatieve Gilde Healthcare IV U.A. (Reporting) CIK: 0001756335 (see all company filings)

State of Incorp.: P7 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40241 | Film No.: 25823215

Mailing Address NEWTONLAAN 91 UTRECHT P7 3584 BP
Business Address NEWTONLAAN 91 UTRECHT P7 3584 BP 949-396-6322
Gilde Healthcare IV Management B.V. (Reporting) CIK: 0001757508 (see all company filings)

State of Incorp.: P7 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40241 | Film No.: 25823214

Mailing Address YALELAAN 62 UTRECHT P7 3584 CM
Business Address YALELAAN 62 UTRECHT P7 3584 CM 31 6 3000 3035
LAVA Therapeutics NV (Issuer) CIK: 0001840748 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)